Paper - WANFANG MED ONLINE

You Position: Home > Paper

Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease?

( views:16, downloads:5 )

Author:: No author available

Journal Title:: Neural Regeneration Research

Issue:: 6

DOI:: No doi available

Key Word:: aging;Alzheimer's disease;amyloid-β;Aβ oligomers;hippocampus;long-term depression;long-term potentiation;LTD;LTP;metabotropic glutamate receptor;N-methyl-D-aspartate receptor;tau hyperphosphorylation;tau phosphorylation;tau

Abstract： Cognitive decline in Alzheimer's disease correlates with the extent of tau pathology,in particular tau hyperphosphorylation that initially appears in the transentorhinal and related regions of the brain including the hippocampus.Recent evidence indicates that tau hyperphosphorylation caused by either amyloid-β or long-term depression,a form of synaptic weakening involved in learning and memory,share similar mechanisms.Studies from our group and others demonstrate that long-term depression-inducing low-frequency stimulation triggers tau phosphorylation at different residues in the hippocampus under different experimental conditions including aging.Conversely,certain forms of long-term depression at hippocampal glutamatergic synapses require endogenous tau,in particular,phosphorylation at residue Ser396.Elucidating the exact mechanisms of interaction between tau and long-term depression may help our understanding of the physiological and pathological functions of tau/tau(hyper)phosphorylation.We first summarize experimental evidence regarding tau-long-term depression interactions,followed by a discussion of possible mechanisms by which this interplay may influence the pathogenesis of Alzheimer's disease.Finally,we conclude with some thoughts and perspectives on future research about these interactions.

Reference

[1]Tariq Ahmed,Ann Van der Jeugd,David Blum,etc.Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion.[J].2014,35(11).
[2]Alberto, Gómez-Ramos,Miguel, Díaz-Hernández,Alicia, Rubio,etc.Characteristics and consequences of muscarinic receptor activation by tau protein.[J].2009,19(10).
[3]Takashi Horiguchi,Kunihiro Uryu,Benoit I. Giasson,etc.Nitration of Tau Protein Is Linked to Neurodegeneration in Tauopathies[J].2003,163(3).
[4]Jeffrey C. Magee,Christine Grienberger.Synaptic Plasticity Forms and Functions[J].2020,43.
[5]Scullion, Sarah E.,Barker, Gareth R. I.,Warburton, E. Clea,etc.Muscarinic Receptor-Dependent Long Term Depression in the Perirhinal Cortex and Recognition Memory are Impaired in the rTg4510 Mouse Model of Tauopathy[J].2019,44(3).
[6]Jing,Wang,Ran,Xie,Xiaolin,Kou,etc.A protein phosphatase 2A deficit in the hippocampal CA1 area impairs memory extinction.[J].2019,12(1).
[7]Busche Marc Aurel,Hyman Bradley T..Synergy between amyloid-β and tau in Alzheimer’s disease[J].2020,23(10).
[8]Sanderson, Jennifer L.,Gorski, Jessica A.,Dell'Acqua, Mark L..NMDA Receptor-Dependent LTD Requires Transient Synaptic Incorporation of Ca2+-Permeable AMPARs Mediated by AKAP150-Anchored PKA and Calcineurin[J].2016,89(5).
[9]Cristian A Lasagna-Reeves,Diana L Castillo-Carranza,Urmi Sengupta,etc.Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice[J].2011,6(1).
[10]Hou, Yujun,Dan, Xiuli,Babbar, Mansi,etc.Ageing as a risk factor for neurodegenerative disease[J].2019,15(10).
[11]Henstridge, Christopher M.,Hyman, Bradley T.,Spires-Jones, Tara L..Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis[J].2019,20(2).
[12]Leboucher, Antoine,Ahmed, Tariq,Caron, Emilie,etc.Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model[J].2019,125.
[13]Neng-Wei, Hu,Grant T, Corbett,Steven, Moore,etc.Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity.[J].2018,23(7).
[14]Regan, Philip,Piers, Thomas,Yi, Jee-Hyun,etc.Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD[J].2015,35(12).
[15]Corbett, Grant T.,Wang, Zemin,Hong, Wei,etc.PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins[J].2020,139(3).
[16]Peter R. Moult,Sônia A. L. Corrêa,Graham L. Collingridge,etc.Co‐activation of p38 mitogen‐activated protein kinase and protein tyrosine phosphatase underlies metabotropic glutamate receptor‐dependent long‐term depression[J].2008,586(10).
[17]Camille,Pernègre,Antoine,Duquette,Nicole,Leclerc.Tau Secretion: Good and Bad for Neurons.[J].2019,13.
[18]Hansson Oskar.Biomarkers for neurodegenerative diseases[J].2021,27(6).
[19]Heynen AJ,Bear MF,Shuler MG,etc.Learning induces long-term potentiation in the hippocampus.[J].2006,313(5790).
[20]M, Novák.Truncated tau protein as a new marker for Alzheimer's disease.[J].1994,38(3).
[21]Sato, Chihiro,Barthelemy, Nicolas R.,Mawuenyega, Kwasi G.,etc.Tau Kinetics in Neurons and the Human Central Nervous System[J].2018,97(6).
[22]Li S,Shepardson NE,Hong S.Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.[J].2009,62(6).
[23]Haas,L.T.,Kostylev,M.A.,Strittmatter,S.M..Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5)[J].2014,289(41).
[24]Cortes, Nicole,Guzman-Martinez, Leonardo,Andrade, Victor,etc.CDK5: A Unique CDK and Its Multiple Roles in the Nervous System[J].2019,68(3).
[25]S D, Yan,X, Chen,A M, Schmidt,etc.Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.[J].1994,91.
[26]Posada-Duque, Rafael Andres,Ramirez, Omar,Hartel, Steffen,etc.CDK5 downregulation enhances synaptic plasticity[J].2017,74(1).
[27]Trepanier, Catherine H.,MacDonald, John F.,Jackson, Michael F..Regulation of NMDA receptors by the tyrosine kinase Fyn[J].2012,279(1).
[28]Jocelyn, Widagdo,Huaqiang, Fang,Se Eun, Jang,etc.PACSIN1 regulates the dynamics of AMPA receptor trafficking.[J].2016.
[29]Amadoro, G.,Latina, V.,Corsetti, V.,etc.N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach[J].2020,1866(3).
[30]Hefti, Marco M.,Kim, SoongHo,Bell, Aaron J.,etc.Tau Phosphorylation and Aggregation in the Developing Human Brain[J].2019,78(10).
[31]Lauretti, Elisabetta,Dincer, Ozlem,Pratico, Domenico.Glycogen synthase kinase-3 signaling in Alzheimer's disease[J].2020,1867(5).
[32]Jin,Miao,Ruirui,Shi,Longfei,Li,etc.Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo.[J].2019,11.
[33]Tetsuya Kimura,Daniel J. Whitcomb,Jihoon Jo,etc.Microtubule-associated protein tau is essential for long-term depression in the hippocampus[J].2014,369(1633).
[34]Andrea Princz,Nektarios Tavernarakis.SUMOylation in Neurodegenerative Diseases[J].2020,66(2).
[35]Elisabetta Lauretti,Domenico Praticò.Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein[J].2020,24(4).
[36]Erica,Acquarone,Elentina K,Argyrousi,Manon,van den Berg,etc.Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.[J].2019,14(1).
[37]Kimura Tetsuya,Suzuki Mamiko,Akagi Takumi.Age-dependent changes in synaptic plasticity enhance tau oligomerization in the mouse hippocampus[J].2017,5(1).
[38]Zilka N,Filipcik P,Koson P,etc.Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo[J].2006,580(15).
[39]Xia Yuxing,Prokop Stefan,Giasson Benoit I..“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies[J].2021,16(1).
[40]Matthew R,Barron,Jane,Gartlon,Lee A,Dawson,etc.Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.[J].2020,11.
[41]Thomas C, Foster,Ashok, Kumar.Susceptibility to induction of long-term depression is associated with impaired memory in aged Fischer 344 rats.[J].2007,87(4).
[42]Marta Vieira,Xuan Ling Hilary Yong,Katherine W. Roche,etc.Regulation of NMDA glutamate receptor functions by the GluN2 subunits[J].2020,154(2).
[43]Cristian A, Lasagna-Reeves,Diana L, Castillo-Carranza,Urmi, Sengupta,etc.Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau.[J].2012,2.
[44].Autonomous CaMKII Mediates Both LTP and LTD Using a Mechanism for Differential Substrate Site Selection[J].2014,6(3).
[45]J Z, Wang,I, Grundke-Iqbal,K, Iqbal.Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.[J].1996,2(8).
[46]Styr, Boaz,Slutsky, Inna.Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease[J].2018,21(4).
[47]Rankovic, Marija,Zweckstetter, Markus.Upregulated levels and pathological aggregation of abnormally phosphorylated Tau-protein in children with neurodevelopmental disorders[J].2019,98.
[48]S.L. Angulo,R. Orman,S.A. Neymotin,etc.Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit[J].2017,108.
[49]Ahmed, Tariq,Blum, David,Burnouf, Sylvie,etc.Rescue of impaired late-phase long-term depression in a tau transgenic mouse model[J].2015,36(2).
[50]Wesseling, Hendrik,Mair, Waltraud,Kumar, Mukesh,etc.Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease[J].2020,183(6).
[51]Ondrejcak, Tomas,Klyubin, Igor,Corbett, Grant T.,etc.Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo[J].2018,38(50).
[52]I, Grundke-Iqbal,K, Iqbal,Y C, Tung,etc.Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.[J].1986,83.
[53]Bos, Isabelle,Vos, Stephanie,Verhey, Frans,etc.Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum[J].2019,15(5).
[54]Arendt T,Stieler J,Strijkstra AM,etc.Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals.[J].2003,23(18).
[55]Benarroch, Eduardo E..Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease Emerging mechanisms[J].2018,91(3).
[56]Shuko, Takeda,Susanne, Wegmann,Hansang, Cho,etc.Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.[J].2015,6.
[57]Jouvenceau A,Kollen M,Billard JM,etc.Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats.[J].2010,9(5).
[58]Kotecha SA,Jackson MF,Al Mahrouki A,etc.Co-stimulation of mGluR5 and N-methyl-D-aspartate receptors is required for potentiation of excitatory synaptic transmission in hippocampal neurons.[J].2003,278(30).
[59]M, Fá,D, Puzzo,R, Piacentini,etc.Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.[J].2016.
[60]Gibbons, Garrett S.,Lee, Virginia M. Y.,Trojanowski, John Q..Mechanisms of Cell-to-Cell Transmission of Pathological Tau A Review[J].2019,76(1).
[61]Pampuscenko, Katryna,Morkuniene, Ramune,Krasauskas, Lukas,etc.Distinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures[J].2021,58(2).
[62]Matos M,Augusto E,Agostinho P,etc.Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.[J].2008,156(4).
[63]Eszter C, Szabó,Rita, Manguinhas,Rosalina, Fonseca.The interplay between neuronal activity and actin dynamics mimic the setting of an LTD synaptic tag.[J].2016.
[64]Liu,D.-D.,Yang,Q.,Li,S.-T..Activation of extrasynaptic NMDA receptors induces LTD in rat hippocampal CA1 neurons[J].2013,93.
[65]Collingridge GL,Peineau S,Lo E,etc.LTP inhibits LTD in the hippocampus via regulation of GSK3beta.[J].2007,53(5).
[66]Sam F. Cooke,Mark F. Bear.How the mechanisms of long-term synaptic potentiation and depression serve experience-dependent plasticity in primary visual cortex[J].2014,369(1633).
[67]Liang, Qiang,Xiaohuan, Sun,Timothy O, Austin,etc.Tau Does Not Stabilize Axonal Microtubules but Rather Enables Them to Have Long Labile Domains.[J].2018,28(13).
[68]Mondragón-Rodríguez,S.,Trillaud-Doppia,E.,Dudilot,A.,etc.Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation[J].2012,287(38).
[69]Shah, Kavita,Lahiri, Debomoy K..A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5[J].2017,54(3).
[70]Papouin, T.,Ladépêche, L.,Ruel, J.,etc.Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists[J].2012,150(3).
[71]Momoko,Ebashi,Yoshinori,Ito,Miho,Uematsu,etc.How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.[J].2019,7(1).
[72]Florian Plattner,Adan Hernez,Tara M. Kistler,etc.Memory Enhancement by Targeting Cdk5 Regulation of NR2B[J].2014,81(5).
[73]Ondrejcak, Tomas,Hu, Neng-Wei,Qi, Yingjie,etc.Soluble tau aggregates inhibit synaptic long-term depression and amyloid beta-facilitated LTD in vivo[J].2019,127.
[74]Ittner, L. M.,Ke, Y. D.,Delerue, F.,etc.Dendritic Function of Tau Mediates Amyloid-b Toxicity in Alzheimers Disease Mouse Models[J].2010,142(3).
[75]Noemí,Pallas-Bazarra,Jonathan,Draffin,Raquel,Cuadros,etc.Tau is required for the function of extrasynaptic NMDA receptors.[J].2019,9(1).
[76]Konstantinos Sarantis,Eirini Tsiamaki,Stylianos Kouvaros,etc.Adenosine A2A receptors permit mGluR5‐evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation[J].2015,135(4).
[77]Grover A,Kehoe K,McGowan E,etc.CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.[J].2004,13(7).
[78]Zetterberg Henrik,Blennow Kaj.Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics[J].2021,16(1).
[79]Viktoriya,Morozova,Leah S,Cohen,Ali El-Hadi,Makki,etc.Normal and Pathological Tau Uptake Mediated by M1/M3 Muscarinic Receptors Promotes Opposite Neuronal Changes.[J].2019,13.
[80]Jadhav Santosh,Avila Jesus,Schöll Michael,etc.A walk through tau therapeutic strategies[J].2019,7(1).
[81]Anwyl R,Kim JH,Djamgoz MB,etc.Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo.[J].2001,21(4).
[82]Beattie Eric C.,Carroll Reed C.,Yu Xiang,etc.Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD[J].2000,3(12).
[83]Emily,Hill,Thomas K,Karikari,Kevin G,Moffat,etc.Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity.[J].2020,6(5).
[84]Knopman David S.,Amieva Helene,Petersen Ronald C.,etc.Alzheimer disease[J].2021,7(1).
[85]Hu, Neng-Wei,Nicoll, Andrew J.,Zhang, Dainan,etc.mGlu5 receptors and cellular prion protein mediate amyloid-beta-facilitated synaptic long-term depression in vivo[J].2014,5(Mar.).
[86]Süer Cem,Yıldız Nurbanu,Barutçu Özlem,etc.Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus[J].2021,73(3).
[87]Padmanabhan Pranesh,Kneynsberg Andrew,Götz Jürgen.Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease[J].2021,22(12).
[88]Carolyn A, Rankin,Qian, Sun,Truman C, Gamblin.Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology.[J].2007,2.
[89]Van der Jeugd A,Ahmed T,Burnouf S,etc.Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.[J].2011,95(3).
[90]Alexis, Bretteville,Fran?ois, Marcouiller,Carl, Julien,etc.Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors.[J].2012,2.
[91]J.Julius Zhu,Yi Qin,Mingming Zhao,etc.Ras and Rap Control AMPA Receptor Trafficking during Synaptic Plasticity[J].2002,110(4).
[92]Tomohide, Mishiba,Mika, Tanaka,Naoki, Mita,etc.Cdk5/p35 functions as a crucial regulator of spatial learning and memory.[J].2014,7.
[93]Brion JP,Begard S,Bretteville A,etc.Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.[J].2006,169(2).
[94]RM Mulkey,CE Herron,RC Malenka.An essential role for protein phosphatases in hippocampal long-term depression[J].1993,261 (5124).
[95]Kent, Sarah A.,Spires-Jones, Tara L.,Durrant, Claire S..The physiological roles of tau and A beta: implications for Alzheimer's disease pathology and therapeutics[J].2020,140(4).
[96]Connor, Steven A.,Wang, Yu Tian.A Place at the Table: LTD as a Mediator of Memory Genesis[J].2016,22(4).
[97]Tracy, Tara E.,Sohn, Peter Dongmin,Minami, S. Sakura,etc.Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss[J].2016,90(2).
[98]Collingridge GL,Peineau S,Howland JG,etc.Long-term depression in the CNS.[J].2010,11(7).
[99]Goran, ?imi?,Mirjana, Babi? Leko,Selina, Wray,etc.Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.[J].2016.
[100]Busche, Marc Aurel,Wegmann, Susanne,Dujardin, Simon,etc.Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo[J].2019,22(1).